Seeing Is Believing
Currently out of the existing stock ratings of Graham Doyle, 9 are a SELL (25.71%), 15 are a HOLD (42.86%), 11 are a BUY (31.43%).
Analyst Graham Doyle, currently employed at UBS, carries an average stock price target met ratio of 46.67% that have a potential upside of 25.07% achieved within 236 days.
Graham Doyle’s has documented 55 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GEHC, GE HealthCare Technologies at 15-Jan-2026.
Analyst best performing recommendations are on PHG (KONINKLIJKE PHILIPS NV ADR).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 9/2/2022. The price target of $16.49 was fulfilled within 7 days with a profit of $1.47 (9.79%) receiving and performance score of 13.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 28-Jul-2022
$36
$-0.9 (-2.44%)
$27
6 months 13 days ago
(18-Aug-2025)
5/7 (71.43%)
$0.01 (0.03%)
416
Hold Since 12-Mar-2025
11 months 19 days ago
(12-Mar-2025)
0/3 (0%)
$-10.44 (-43.85%)
Buy Since 03-Nov-2023
$15.29
$-21.61 (-58.56%)
$15.07
2 years 4 months ago
(03-Nov-2023)
7/14 (50%)
$-7.54 (-33.03%)
673
Buy Since 14-Apr-2023
$33
$-3.9 (-10.57%)
$39.5
2 years 4 months 27 days ago
(04-Oct-2023)
2/3 (66.67%)
$10.75 (48.31%)
762
Buy Since 11-Apr-2023
$16.94
$-19.96 (-54.09%)
$14.12
2 years 10 months 20 days ago
(11-Apr-2023)
0/3 (0%)
$-10.46 (-38.18%)
Which stock is Graham Doyle is most bullish on?
What Year was the first public recommendation made by Graham Doyle?